[go: up one dir, main page]

CN1638784A - skin topical composition - Google Patents

skin topical composition Download PDF

Info

Publication number
CN1638784A
CN1638784A CNA038048922A CN03804892A CN1638784A CN 1638784 A CN1638784 A CN 1638784A CN A038048922 A CNA038048922 A CN A038048922A CN 03804892 A CN03804892 A CN 03804892A CN 1638784 A CN1638784 A CN 1638784A
Authority
CN
China
Prior art keywords
skin
kefir
extract
preparation
external application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA038048922A
Other languages
Chinese (zh)
Other versions
CN100551348C (en
Inventor
德丸千之助
德丸浩一郎
白畑实隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Kefir Co ltd
Original Assignee
Nihon Kefir Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Kefir Co ltd filed Critical Nihon Kefir Co ltd
Publication of CN1638784A publication Critical patent/CN1638784A/en
Application granted granted Critical
Publication of CN100551348C publication Critical patent/CN100551348C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986Milk; Derivatives thereof, e.g. butter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Disclosed is a composition for external application to the skin, which comprises a fermented milk product obtained from Kefia grain and a pharmaceutically or cosmetically acceptable carrier; a method of treating skin using the above composition; the application of the composition; cell activator, skin aging inhibitor, whitening agent or melanin generation inhibitor containing fermented milk product obtained from kefir milk granule is provided. The above-mentioned composition for external application to the skin contains, as an active ingredient, a fermented milk product obtained from kefir grains, preferably kefir and/or kefir whey. These skin external compositions are very suitable for use as cosmetic compositions, scalp/hair care compositions, dermatological treatment compositions, and the like, because of having various advantageous effects of activating cells, preventing skin aging, whitening, inhibiting melanogenesis, and the like.

Description

皮肤外用组合物skin topical composition

技术领域technical field

本发明涉及一种皮肤外用制剂,其含有从开菲乳(Kefir)开菲乳颗粒获得的发酵乳制品。尤其是,本发明涉及一种皮肤外用制剂,其中含有从中开菲乳颗粒得到的发酵乳制品开菲乳(Kefir)和/或开菲乳清(Kefir whey)开菲乳颗粒。本发明的皮肤外用制剂非常适于用作化妆产品,用于头皮和毛发的组合物,用于清洁皮肤的组合物,用于皮肤病的治疗用组合物等,其具有出色的细胞活化功效,抗皮肤老化的功效,增白功效,抑制黑色素生成的功效等等。The present invention relates to an external skin preparation containing a fermented milk product obtained from kefir kefir granules. In particular, the present invention relates to an external skin preparation containing kefir and/or kefir whey kefir granules, a fermented dairy product obtained therefrom, from kefir granules. The skin external preparation of the present invention is very suitable as a cosmetic product, a composition for the scalp and hair, a composition for cleansing the skin, a composition for treatment of skin diseases, etc., which has an excellent cell activation effect, Anti-aging effect, whitening effect, effect of inhibiting melanin production, etc.

背景技术Background technique

皮肤活性不仅受诸如老化的内环境的显著影响,也受诸如紫外射线和各种刺激的外环境的影响,,由此容易引起一些皮肤问题,诸如皮肤粗糙,皱纹,斑点,皮肤黯淡。为了缓解这些问题,人们检测了大量的皮肤活化成分。其中,专门针对细胞活化成分和增白成分作了大量研究。细胞活化成分可刺激细胞分裂,增强新陈代谢并对维持肌体健康起到很好的效果。并且,所述成分可活化表皮角质细胞,促使老化角质细胞脱落并促进被称作皮肤更新的角质化过程,从而改善皮肤至健康、美观的状态。Skin activity is significantly affected not only by the internal environment such as aging, but also by the external environment such as ultraviolet rays and various stimuli, thereby easily causing some skin problems such as rough skin, wrinkles, spots, and dull skin. In order to alleviate these problems, a large number of skin-activating ingredients have been tested. Among them, a lot of research has been done on cell activation components and whitening components. Cell activating ingredients can stimulate cell division, enhance metabolism and have a good effect on maintaining body health. Also, the ingredients activate epidermal keratinocytes, exfoliate aged keratinocytes and promote a keratinization process called skin renewal, thereby improving the skin to a healthy, aesthetically pleasing state.

开菲乳是高加索地区的一种传统发酵乳制品。它是一种类似于酸乳的饮料,通过采用一种称为开菲乳颗粒的种子菌株作为菌母发酵哺乳动物奶乳而得到。尤其是,这种类似于酸乳的发酵乳制品的透明液体部分称为开菲乳清。开菲乳可以是几乎所有水分都去除的干态,也可以是含有相对较多水分的凝胶态。生产干态开菲乳的方法公开于诸如JP-83842/1987公报中并且生产开菲乳清的方法则公开于JP-219538/1990公报中。上述文献的公开内容均在此引入作为参考。Kefir is a traditional fermented dairy product from the Caucasus region. It is a drink similar to yogurt obtained by fermenting mammalian milk using a seed strain called kefir granule as the mother bacteria. In particular, the clear liquid part of this yogurt-like fermented dairy product is called kefir. Kefir can be in a dry state from which almost all the water has been removed, or in a gel state with relatively more water. A method for producing dry kefir milk is disclosed in, for example, JP-83842/1987 publication and a method for producing kefir whey is disclosed in JP-219538/1990 publication. The disclosure content of the above-mentioned documents is hereby incorporated by reference.

此外,很多人热衷于开菲乳的研究,不仅为得到健康食品,也因为集中在其出色健康功效的药物应用(JP-320069/1993公报,JP-211668/1994公报,JP-37711/1997公报,JP-191852/1997公报等)。所进行的大部分研究和开发目标均在于口服摄入含有开菲乳的食品或药物组合物。In addition, many people are keen on the research of kefir, not only to obtain healthy food, but also because of the application of drugs focused on its excellent health effects (JP-320069/1993 communique, JP-211668/1994 communiqué, JP-37711/1997 communique , JP-191852/1997 bulletin, etc.). Most of the research and development carried out is aimed at the oral ingestion of food or pharmaceutical compositions containing kefir milk.

尽管开菲乳具有出色的效果,但是由于最初是作为发酵乳饮料,并且具有独特口味和pH特征(约4.20-4.40),因而与其它常见酸乳产品相比很难用于除口服产品外的其它方面,诸如皮肤外用制剂,尤其是当使用时需要更好触感的化妆品方面。Although kefir has excellent effects, it is difficult to use in addition to oral products compared to other common yogurt products due to its original taste and pH characteristics (about 4.20-4.40) as a fermented milk drink. Other aspects, such as skin topical preparations, especially cosmetic aspects that require a better touch when applied.

另一方面,健康的概念正在向多方面扩展并且开始不仅包括精神和身体方面而且也包括属于美容领域的外貌,诸如皮肤。为了维护扩展意义上的健康,除了预料具有快速效果的药物外,在日常生活中也需要各种显效慢但是安全并且使用简便的产品。On the other hand, the concept of health is being multifaceted and beginning to include not only mental and physical aspects but also appearance, such as skin, belonging to the field of beauty. In order to maintain health in an extended sense, in addition to drugs expected to have a quick effect, various slow-acting but safe and easy-to-use products are also required in daily life.

发明内容Contents of the invention

鉴于这些情况,本发明人一直专注于从开菲乳颗粒得到的传统增进健康的食品发酵乳制品的功能,即安全,热稳定性和对皮肤诸如细胞活化的效果,并且通过克服上述缺陷并利用所述发酵乳制品的特性完成了本发明。In view of these circumstances, the present inventors have been focusing on the functions of fermented milk products obtained from kefir granules as a traditional health-enhancing food, namely, safety, thermal stability, and effects on skin such as cell activation, and by overcoming the above-mentioned defects and utilizing The properties of said fermented milk products complete the present invention.

换句话说,本发明涉及一种皮肤外用制剂的组合物,其含有从开菲乳颗粒获得的发酵乳制品,及其药用和化妆品用载体。同样地,本发明涉及一种皮肤外用制剂的组合物,例如化妆品组合物,用于头皮和毛发的组合物,以及用于皮肤清洁剂的组合物,进一步地含有一种或多种选自如下的成分:自由基清除成分,抗氧化剂成分,消炎成分,紫外线防护成分及保湿成分。此外,本发明涉及含有本发明发酵乳制品的细胞活化剂,抗老化剂,皮肤增白剂或黑色素生成抑制剂。In other words, the present invention relates to a composition of an external preparation for skin comprising a fermented milk product obtained from kefir granules, and a pharmaceutically and cosmetically acceptable carrier thereof. Likewise, the present invention relates to a composition for external use on skin, such as a cosmetic composition, a composition for scalp and hair, and a composition for skin cleanser, further comprising one or more selected from the following Ingredients: free radical scavenging ingredients, antioxidant ingredients, anti-inflammatory ingredients, UV protection ingredients and moisturizing ingredients. Furthermore, the present invention relates to a cell activator, an antiaging agent, a skin whitening agent or a melanin production inhibitor containing the fermented milk product of the present invention.

同样,本发明涉及通过将从开菲乳颗粒获得的有效量发酵乳制品施用于皮肤从而活化皮肤细胞,抗皮肤老化,抑制皮肤黑色素生物合成,和/或增白皮肤的方法。本发明方法的优选实施例包括用于化妆或清洁皮肤的方法,用于化妆或清洁头皮和/或毛发的方法,用于治疗皮肤病患者皮肤的方法等。Also, the present invention relates to methods for activating skin cells, anti-aging skin, inhibiting skin melanin biosynthesis, and/or whitening skin by applying to skin an effective amount of fermented milk product obtained from kefir granules. Preferred embodiments of the method of the present invention include a method for making up or cleansing the skin, a method for making up or cleansing the scalp and/or hair, a method for treating the skin of a dermatological patient, and the like.

此外,本发明涉及从开菲乳颗粒获得的发酵乳制品在生产皮肤外用制剂组合物中的应用。Furthermore, the present invention relates to the use of a fermented milk product obtained from kefir granules in the production of a skin external preparation composition.

附图说明Description of drawings

图1.是作为显示实验实施例1结果示图的照片。FIG. 1 is a photograph as a graph showing the results of Experimental Example 1. FIG.

图2.是显示实验实施例1结果的示图(hMLH1)。Fig. 2. is a graph showing the results of Experimental Example 1 (hMLH1).

图3.是显示实验实施例1结果的示图(hPMS1)。Fig. 3. is a graph showing the results of Experimental Example 1 (hPMS1).

图4.是显示实验实施例1结果的示图(hPMS2)。Fig. 4. is a graph showing the results of Experimental Example 1 (hPMS2).

图5.是作为显示实验实施例2结果示图的照片。Fig. 5. is a photograph as a graph showing the results of Experimental Example 2.

图6.是显示实验实施例2结果的示图(hMLH1)。Fig. 6. is a graph showing the results of Experimental Example 2 (hMLH1).

图7.是作为显示实验实施例3结果示图的照片。Fig. 7. is a photograph as a graph showing the results of Experimental Example 3.

图8.是显示实验实施例3结果的示图。Fig. 8. is a graph showing the results of Experimental Example 3.

图9.是作为显示实验实施例4(1)结果示图的照片。Fig. 9. is a photograph as a graph showing the results of Experimental Example 4(1).

图10.是显示实验实施例4(1)结果的示图。Fig. 10. is a graph showing the results of Experimental Example 4(1).

图11.是作为显示实验实施例4(2)结果示图的照片。Fig. 11. is a photograph as a graph showing the results of Experimental Example 4(2).

图12.是显示实验实施例4(2)结果的示图。Fig. 12. is a graph showing the results of Experimental Example 4(2).

图13.是作为显示实验实施例4(3)结果示图的照片。Fig. 13. is a photograph as a graph showing the results of Experimental Example 4(3).

图14.是显示实验实施例4(3)结果的示图。Fig. 14. is a graph showing the results of Experimental Example 4(3).

图15.是显示实验实施例5结果的示图。Fig. 15. is a graph showing the results of Experimental Example 5.

实施本发明的最佳方式Best Mode for Carrying Out the Invention

用于本发明的从开菲乳颗粒得到的发酵乳制品可通过对哺乳动物奶乳,大豆奶,粉状脱脂奶等由颗粒状细菌进行发酵而得到,所述颗粒状细菌为称作开菲乳颗粒的种子菌株,其含有诸如乳酸,酵母等的至少5-6种组合功能等。当将开菲乳颗粒接种于哺乳动物奶诸如牛奶或山羊奶,大豆奶,脱脂奶等中时,可发生乳酸杆菌的乳酸发酵和酵母的乙醇发酵。开菲乳颗粒的发酵奶制品有别于只通过乳酸杆菌发酵而成的酸乳,有一股酸味,并且除了由酵母释放的二氧化碳气体引起的轻微酒精味道外,还有一种刺激性气味。同样,所述的发酵奶制品富含养分,诸如乳糖,肽,氨基酸,乳酸,维生素,矿物质给我们的身体带来很好的效果。The fermented milk product obtained from kefir granules used in the present invention can be obtained by fermenting mammalian milk, soybean milk, powdered skim milk, etc., with granular bacteria called kefir The seed strain of milk granules, which contains at least 5-6 combined functions such as lactic acid, yeast, etc. When kefir particles are inoculated into mammalian milk such as cow's or goat's milk, soybean milk, skim milk, etc., lactic acid fermentation by lactobacillus and ethanol fermentation by yeast can occur. The fermented milk product of kefir granules is different from yogurt fermented only by lactobacillus, has a sour taste, and has a pungent smell in addition to the slight alcohol taste caused by the carbon dioxide gas released by the yeast. Also, said fermented milk products are rich in nutrients such as lactose, peptides, amino acids, lactic acid, vitamins, minerals to bring good effects to our body.

本发明中采用的发酵奶制品可以通过普通哺乳动物奶乳发酵得到。哺乳动物奶乳的实例包括牛奶,马奶,绵羊奶,山羊奶,水牛奶等等。从哺乳动物奶生产发酵产品的方法不限于但可以是传统方法,诸如采用普通牛奶为原料并用开菲乳颗粒进行发酵,或者采用东欧较常见的马奶。然而,优选的是以牛奶为原料,用开菲乳颗粒发酵得到的产物(见JP-83842/1987公报)。The fermented milk product used in the present invention can be obtained by fermenting common mammalian milk. Examples of mammalian milk include cow's milk, mare's milk, sheep's milk, goat's milk, buffalo's milk, and the like. The method of producing fermented products from mammalian milk is not limited to but can be a traditional method, such as using ordinary cow's milk as raw material and fermenting with kefir granules, or using mare's milk which is more common in Eastern Europe. However, it is preferred to use cow's milk as a raw material and obtain the product fermented with kefir granules (see JP-83842/1987 communique).

另外,可以采用普通大豆奶,粉状脱脂奶等等通过开菲乳颗粒生产得到发酵奶制品。In addition, ordinary soybean milk, powdered skim milk, etc. can be used to produce fermented milk products through kefir granules.

对于本发明中的开菲乳和开菲乳清而言,上文提及的发酵奶制品中类似于酸乳的物质或其干态成分即称为开菲乳,而从类似于酸乳的物质得到的透明液体成分即称为开菲乳清。本发明中采用的从开菲乳颗粒得到的发酵乳制品的优选实施例可以是开菲乳或开菲乳清,或者二者的混合物。For the kefir and kefir whey in the present invention, the above-mentioned fermented milk products similar to yoghurt or their dry components are called kefir, and from the yoghurt-like The resulting transparent liquid component is called kefir whey. A preferred embodiment of the fermented milk product obtained from kefir granules used in the present invention may be kefir or kefir whey, or a mixture of both.

本发明中采用的从开菲乳颗粒得到的发酵乳制品,开菲乳表现出多方面的用途,包括保湿效果,紫外线防护效果,抑制黑色素生成的效果,自由基去除效果以及细胞活化效果等等。由于它还表现出热稳定性并且可进行过滤除菌,因而可用于皮肤的稳定外用制品,特别是用于化妆品材料。虽然它具有由酵母发酵和乳酸发酵而产生的独特气味和4.20-4.40的pH特征,通过与其它化妆品原料或载体混合,其可望能在使用中获得更好的感觉,并能表现出有益效果和效用。The fermented milk product obtained from kefir granules used in the present invention, kefir exhibits various uses, including moisturizing effect, ultraviolet protection effect, melanin production inhibiting effect, free radical removal effect and cell activation effect, etc. . Since it also exhibits heat stability and is filter sterilizable, it can be used in stable external preparations for the skin, especially in cosmetic materials. Although it has a unique smell produced by yeast fermentation and lactic acid fermentation and a pH characteristic of 4.20-4.40, by mixing with other cosmetic raw materials or carriers, it is expected to have a better feeling in use and show beneficial effects and utility.

本发明中采用的开菲乳可以是类似于酸乳的形态,或者是通过干燥(冷冻干燥等)类似于酸乳的开菲乳而得到的粉末状,或者是对粉末状开菲乳进一步处理而得到的颗粒状。也可以是用水,缓冲液,酒精,油等等处理而得到的液态。The kefir used in the present invention can be in a form similar to yogurt, or in the form of a powder obtained by drying (freeze-drying, etc.) kefir similar to yogurt, or by further processing the powdered kefir And the obtained granular. It may also be in a liquid state obtained by treatment with water, buffer, alcohol, oil, etc.

当所述开菲乳用于皮肤外用制剂时,以外用制剂总重计其优选地包含0.01-3.00wt%的开菲乳,优选地包括1.00-3.00wt%的开菲乳。When the kefir is used in an external preparation for skin, it preferably contains 0.01-3.00 wt% kefir, preferably 1.00-3.00 wt%, based on the total weight of the external preparation.

另外,本发明中采用的开菲乳清是从上述类似于酸乳的发酵奶制品中得到一种透明液体成分,又称作“乳血清”。其富含诸如乳糖,肽,氨基酸,乳酸,维生素,矿物质的养分;并且认为含有原料奶中约一半的养分。在开菲乳清中,固体含量约6%,其余为水含量。开菲乳清比普通酸乳含有更多的L-乳糖,并且乳酸杆菌的抗菌效果正在引起人们的关注。并且,已经发现开菲乳清可保持皮肤湿度并调节pH至理想的温和酸度,因为开菲乳清的结构与皮肤角蛋白细胞中的NMF(天然保湿因子)结构类似。此外,鉴于其抗过敏效果及出色的保湿效果,开菲乳被认为可以保护皮肤免受外部刺激或细菌侵害。In addition, the kefir whey used in the present invention is a transparent liquid component obtained from the above-mentioned fermented milk products similar to yoghurt, also known as "milk serum". It is rich in nutrients such as lactose, peptides, amino acids, lactic acid, vitamins, minerals; and is considered to contain about half of the nutrients in raw milk. In kefir whey, the solids content is about 6%, and the rest is water content. Kefi whey contains more L-lactose than ordinary yogurt, and the antibacterial effect of Lactobacillus is attracting attention. Also, it has been found that kefir whey maintains skin moisture and adjusts pH to ideal mild acidity because kefir whey has a similar structure to NMF (natural moisturizing factor) in skin keratin cells. In addition, kefir milk is considered to protect the skin from external stimuli or bacteria due to its anti-allergic effect and excellent moisturizing effect.

尽管具有这些有利特性,开菲乳清一直只是被看作废弃物。只是最近其有效利用才引起人们的讨论。Despite these beneficial properties, kefir whey has been viewed as little more than a waste product. Only recently has its effective use been discussed.

本发明中采用的通过开菲乳颗粒发酵得到的乳制品开菲乳清显示出各种有用功效诸如与上述开菲乳相同的保湿效果,紫外线防护效果,抑制黑色素生成的效果,自由基清除效果以及细胞活化效果。同时它还表现出热稳定性,可进行过滤除菌,从而使其可以用作稳定的化妆品原料。它具有由酵母发酵和乳酸发酵而产生的独特气味,以及4.20-4.40的独特pH,然而,将开菲乳与其它化妆品原料或载体混合,其可望在应用中能达到更好的感觉,并能表现出有益效果和效用。The dairy product kefir whey obtained by fermenting kefir granules used in the present invention exhibits various useful effects such as the same moisturizing effect as the above-mentioned kefir, UV protection effect, melanin production inhibiting effect, free radical scavenging effect and cell activation. It also exhibits heat stability and is filter sterilizable, allowing it to be used as a stable cosmetic raw material. It has a unique smell produced by yeast fermentation and lactic acid fermentation, and a unique pH of 4.20-4.40, however, kefir milk is mixed with other cosmetic raw materials or carriers, it is expected to achieve a better feeling in application, and Can exhibit beneficial effects and utility.

当所述的开菲乳清用于皮肤外用制剂时,以外用制剂总重计其优选含量为0.01-3.00的wt%,特别地,优选含量为0.01-3.00wt%。When the kefir whey is used in an external preparation for skin, its preferred content is 0.01-3.00 wt% based on the total weight of the external preparation, especially, the preferred content is 0.01-3.00 wt%.

上述从开菲乳颗粒得到的发酵乳制品,无论是开菲乳或开菲乳清均可用作细胞活化剂,因为其具有如上文所述的细胞活化效果。除此以外,由于其紫外线防护效果,抑制黑色素生成的效果,以及自由基清除效果,它也可用作抗皮肤老化剂和增白剂,并且它显然可用作黑色素生成抑制剂。The above-mentioned fermented milk product obtained from kefir granules, whether it is kefir or kefir whey, can be used as a cell activator because it has the cell activation effect as described above. In addition, it is also useful as an anti-aging skin agent and whitening agent due to its UV protection effect, melanin production inhibiting effect, and free radical scavenging effect, and it is apparently useful as a melanin production inhibitor.

本发明的皮肤外用制剂组合物当用作为药品时,是一种含有从开菲乳颗粒得到的发酵乳制品和可作药用的载体的组合物。当用作化妆产品或清洁剂时,它是一种含有从开菲乳颗粒得到的发酵乳制品和化妆品用载体的组合物。本发明的皮肤外用制剂组合物可含有通常化妆产品、准药物或药物中用于皮肤外用制剂的任何其它所需成分,例如选自如下的一种或多种成分:含量范围不会干扰本发明效果的自由基清除成分,抗氧化剂成分,消炎成分,紫外线防护成分和保湿成分。The skin external preparation composition of the present invention, when used as a drug, is a composition comprising a fermented milk product obtained from kefir granules and a pharmaceutically acceptable carrier. When used as a cosmetic product or cleanser, it is a composition comprising a fermented milk product obtained from kefir granules and a cosmetic carrier. The external preparation composition for skin of the present invention may contain any other desired ingredients used in external preparations for skin in general cosmetic products, quasi-drugs or medicines, for example, one or more ingredients selected from the following: the content range does not interfere with the present invention Effective radical scavenging ingredients, antioxidant ingredients, anti-inflammatory ingredients, UV protection ingredients and moisturizing ingredients.

本发明的皮肤外用制剂组合物可通过与各种所需载体,含油物,润湿剂,表面活性剂,抗菌剂,香料,水,醇类,其他碱,增稠剂等以通常方式适当混合进行生产,所述载体包括例如,诸如凡士林或微晶蜡的碳氢化合物,诸如霍霍巴油或鲸蜡,诸如牛脂或橄榄油的甘油三酯,诸如硬脂酸或油酸的脂肪酸,诸如甘油或1,3-丁二醇的多元醇。The skin external preparation composition of the present invention can be properly mixed with various required carriers, oily substances, wetting agents, surfactants, antibacterial agents, fragrances, water, alcohols, other alkalis, thickeners, etc. For production, the carrier includes, for example, hydrocarbons such as petrolatum or microcrystalline wax, such as jojoba oil or spermaceti, triglycerides such as tallow or olive oil, fatty acids such as stearic acid or oleic acid, such as glycerol or polyols of 1,3-butanediol.

本发明的皮肤外用制剂组合物中含有的自由基清除成分的实例包括一种或多种如下成分:超氧化物歧化酶(SOD),甘露醇,类胡萝卜素,虾青素,芸香苷及其衍生物,胆红素,胆固醇,色氨酸,组氨酸,五羟黄酮,儿茶素及其衍生物,五倍子酸及其衍生物,谷胱甘肽及其衍生物,黄芩提取物,银杏提取物,鸡血藤提取物,野山楂提取物,玫瑰提取物,虎耳草提取物,香蜂草提取物,Geranium thunbergii提取物,牡丹提取物,岩芹提取物,Potentilla tormentilla提取物,Siraitiagrosvenori提取物,Yashajitsu提取物,枸杞根提取物(Lycium chineseroot),甜菊(Stevia rebaudiana)提取物以及Rosa multiflora thunberg提取物。Examples of the free radical scavenging component contained in the skin external preparation composition of the present invention include one or more of the following components: superoxide dismutase (SOD), mannitol, carotenoids, astaxanthin, rutin, and Derivatives, bilirubin, cholesterol, tryptophan, histidine, quercetin, catechin and its derivatives, gallic acid and its derivatives, glutathione and its derivatives, Scutellaria baicalensis extract, Ginkgo biloba Extract, Spatholobus Extract, Wild Hawthorn Extract, Rose Extract, Saxifrage Extract, Lemon Balm Extract, Geranium thunbergii Extract, Peony Extract, Petunia Extract, Potentilla tormentilla Extract, Siraitiagrosvenori extract, Yashajitsu extract, Lycium chinese root extract, Stevia rebaudiana extract and Rosa multiflora thunberg extract.

本发明皮肤外用制剂组合物中含有的抗氧化成分的实例包括一种或多种如下成分:甘露醇,芸香苷及其衍生物,栎精,磷脂,吡哆素,类黄酮,多元酚化合物,银杏提取物,虎耳草提取物,维生素A族及其衍生物,维生素B族及其衍生物,维生素C族及其衍生物,维生素D族及其衍生物,维生素E族及其衍生物,二丁基羟甲苯和丁基羟基苯甲醚。Examples of the antioxidant component contained in the skin external preparation composition of the present invention include one or more of the following components: mannitol, rutin and its derivatives, quercetin, phospholipids, pyridoxine, flavonoids, polyphenolic compounds, Ginkgo biloba extract, saxifrage extract, vitamin A family and its derivatives, vitamin B family and its derivatives, vitamin C family and its derivatives, vitamin D family and its derivatives, vitamin E family and its derivatives, Butylated hydroxytoluene and butyl hydroxyanisole.

本发明的皮肤外用制剂组合物中含有的消炎成分的实例包括一种或多种如下成分:甘草酸及其衍生物,甘草亭酸及其衍生物,甲芬那酸(mefenamic acid)及其衍生物,苯基丁氮酮及其衍生物,indomethacin及其衍生物,布洛芬(ibuprofen)及其衍生物,酮洛芬(ketoprofen)及其衍生物,尿囊素及其衍生物,愈创木薁及其衍生物,ε-氨基己酸,双氯芬酸钠(diclofenac sodium),凝血酸及其衍生物,明日叶(Angelicakeiskei)提取物,山金车提取物,芦荟提取物,蓼提取物,姜黄提取物,小连翘提取物,黄柏提取物,德国洋甘菊(Matricaria chamomilla)提取物,甘草提取物,金银花提取物,水芥菜提取物,康复力(Symphytumofficinale)提取物,五加提取物,鼠尾草提取物,紫草根提取物,紫苏提取物,白桦提取物,茶提取物,金盏花提取物,接骨木花提取物,香蒲(Typha latifolia)提取物,无患子(Sapindus mukurossi)提取物,蒿提取物,桉树提取物,日本当归提取物以及紫云英提取物。Examples of the anti-inflammatory ingredients contained in the skin external preparation composition of the present invention include one or more of the following ingredients: glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, mefenamic acid and its derivatives substances, phenylbutazone and its derivatives, indomethacin and its derivatives, ibuprofen and its derivatives, ketoprofen and its derivatives, allantoin and its derivatives, guaiac Azulene and its derivatives, ε-aminocaproic acid, diclofenac sodium, tranexamic acid and its derivatives, Ashitaba (Angelicakeiskei) extract, arnica extract, aloe vera extract, Polygonum extract, turmeric Extract, Forsythia officinale extract, Phellodendron phellodendri extract, German chamomile (Matricaria chamomilla) extract, Licorice root extract, Honeysuckle extract, Water mustard extract, Symphytumofficinale extract, Acanthopanax extract, Sage tail Grass Extract, Comfrey Root Extract, Perilla Extract, White Birch Extract, Tea Extract, Calendula Flower Extract, Elderflower Extract, Typha latifolia Extract, Sapindus mukurossi Extract Extract, Artemisia Extract, Eucalyptus Extract, Japanese Angelica Extract and Milk Vetch Extract.

本发明的皮肤外用制剂组合物中含有的紫外线防护组分的实例包括一种或多种如下成分:对氨基苯甲酸(PABA),乙基PABA,甘油基PABA,N,N-二甲基PABA-戊基,N,N-二甲基PABA-2-乙基己基,2-乙基己基水杨酸酯,乙二醇水杨酸酯,高薄荷基水杨酸酯,2-乙基己基-4-甲氧基-肉桂酸酯,乙氧基乙基-4-甲氧基-肉桂酸酯,4-甲氧基-肉桂酸钾,甲基-4-5-二异丙基肉桂酸酯,甘油基单-2-乙基-己酸酯,二-p-甲氧基肉桂酸酯,2-羟基-4-甲氧基-二苯甲酮,2-羟基-4-甲氧基-二苯甲酮磺酸酯,2-羟基-4-甲氧基-二苯甲酮磺酸钠,2,2’-二羟基-4,4’-二甲氧基-二苯甲酮,2,2’-二羟基-4,4’-二甲氧基-二苯甲酮-5-磺酸钠,2-4-二羟基二苯甲酮,2,2’,4,4’-四羟基-二苯甲酮,2-(2-羟基-5-甲基苯基)-苯并三唑,咪唑丙烯酸,乙基咪唑丙烯酸酯,4-叔-丁基-4,-甲氧基-二苯甲酰甲烷,二氧化钛,氧化锌,氧化铁,氧化铈以及氧化锆。Examples of the ultraviolet protection component contained in the skin external preparation composition of the present invention include one or more of the following ingredients: p-aminobenzoic acid (PABA), ethyl PABA, glyceryl PABA, N,N-dimethyl PABA -Amyl, N,N-Dimethyl PABA-2-Ethylhexyl, 2-Ethylhexyl Salicylate, Ethyl Glycol Salicylate, Homomenthyl Salicylate, 2-Ethylhexyl -4-methoxy-cinnamate, ethoxyethyl-4-methoxy-cinnamate, potassium 4-methoxy-cinnamate, methyl-4-5-diisopropylcinnamate Esters, Glyceryl mono-2-ethyl-hexanoate, Di-p-methoxycinnamate, 2-Hydroxy-4-methoxy-benzophenone, 2-Hydroxy-4-methoxy - Benzophenone sulfonate, sodium 2-hydroxy-4-methoxy-benzophenone sulfonate, 2,2'-dihydroxy-4,4'-dimethoxy-benzophenone, 2,2'-Dihydroxy-4,4'-dimethoxy-benzophenone-5-sodium sulfonate, 2-4-dihydroxybenzophenone, 2,2',4,4'- Tetrahydroxy-benzophenone, 2-(2-hydroxy-5-methylphenyl)-benzotriazole, imidazole acrylate, ethylimidazole acrylate, 4-tert-butyl-4,-methoxy -Dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide, cerium oxide and zirconium oxide.

本发明的皮肤外用制剂组合物中含有的保湿成分的实例包括一种或多种选自如下的成分:选自透明质酸的粘多糖及其衍生物,硫酸软骨素,硫酸皮肤素,硫酸乙酰肝素,硫酸肝素和角质素;选自胶原、弹性蛋白、纤连蛋白和角质蛋白的蛋白及其衍生物和水解物;选自甘氨酸、丙氨酸、缬氨酸、异亮氨酸、丝氨酸、苏氨酸、天冬氨酸、谷氨酸、天冬酰胺、谷氨酰胺、赖氨酸、羟赖氨酸、精氨酸、半胱氨酸、胱氨酸、甲硫氨酸、苯丙氨酸、酪氨酸、脯氨酸、羟脯氨酸、茶氨酸、orthinine、瓜氨酸、以及吡咯烷酮羧酸酯的氨基酸及其衍生物;选自山梨糖醇、赤藓糖醇、麦芽糖、麦芽糖醇、木糖醇、木糖、海藻糖、肌醇、葡萄糖、季戊四醇、果糖、蔗糖及其酯、以及糊精及其衍生物的糖类;粘蛋白,D-泛醇及其衍生物,尿素,磷脂,糖脂和N-脂酰鞘氨醇,深海水,蜂蜜,红糖提取物,芦荟提取物,海藻提取物,榅桲(Cydonia oblonga)提取物,北美金缕梅提取物,丝瓜提取物,锦葵提取物,苹果提取物,葡萄柚(Citrus paradisi)提取物,欧州李(Prunusdomestica)提取物,Citrus aurantifolia提取物,香橙(Citrus junos)提取物,南京椴(Tilia miqueliana)提取物,悬钩子提取物,苦参(Sophoraflavescens)提取物,大枣(Zizyphus jujuba)提取物,麦芽提取物,茵陈蒿(Artemisia capillaris),白百合(Lilium candidum)提取物,啤酒花提取物,薄荷(Mentha piperita)提取物,鱼腥草提取物,芍药提取物,薏苡提取物,熏衣草提取物,燕麦提取物,假叶树(Ruscus aculeatus)提取物,药蜀葵提取物,茯苓(Wolfiporia cocos)提取物,荨提取物,茴香提取物,猕猴桃(Actinidia chinensis)提取物,黄瓜提取物,葡萄提取物,仙人掌提取物,地黄根提取物,问荆提取物,Cnidium officinale提取物,桑提取物,百里香提取物,马栗树提取物,桃花(Prunus persica)提取物,Rosa damascena提取物,杏树提取物,玉米提取物,姜提取物,酸柠檬提取物,酸橙提取物,草莓提取物,黄龙胆提取物,锦葵提取物,堇菜提取物,牛蒡提取物,羽扇豆提取物,长角豆提取物,常春藤提取物,松树提取物,Rodgersia podophylla提取物,地榆提取物,芒柄花提取物,黄龙胆提取物,八仙花提取物,Fukutanpopodandelion提取物,Cydonia种子提取物,甘油和1,3-丁二醇。Examples of the moisturizing ingredient contained in the skin external preparation composition of the present invention include one or more ingredients selected from the group consisting of mucopolysaccharides and derivatives thereof from hyaluronic acid, chondroitin sulfate, dermatan sulfate, acetyl sulfate Heparin, heparan sulfate and keratin; proteins selected from collagen, elastin, fibronectin and keratin and their derivatives and hydrolysates; selected from glycine, alanine, valine, isoleucine, serine, Threonine, Aspartic Acid, Glutamic Acid, Asparagine, Glutamine, Lysine, Hydroxylysine, Arginine, Cysteine, Cystine, Methionine, Phenylalanine Amino acid and its derivatives of amino acid, tyrosine, proline, hydroxyproline, theanine, orthinine, citrulline, and pyrrolidone carboxylate; selected from sorbitol, erythritol, maltose , maltitol, xylitol, xylose, trehalose, inositol, glucose, pentaerythritol, fructose, sucrose and its esters, and dextrin and its derivatives; mucin, D-panthenol and its derivatives , urea, phospholipids, glycolipids and N-fatty ceramide, deep sea water, honey, brown sugar extract, aloe extract, seaweed extract, quince (Cydonia oblonga) extract, North American witch hazel extract, loofah Extract, Mallow Extract, Apple Extract, Grapefruit (Citrus paradisi) Extract, European Plum (Prunus domestica) Extract, Citrus aurantifolia Extract, Citrus junos Extract, Nanjing Tilia (Tilia miqueliana) Extract Extract, Rubus extract, Sophoraflavescens extract, Zizyphus jujuba extract, Malt extract, Artemisia capillaris, Lilium candidum extract, Hops extract, Peppermint ( Mentha piperita) extract, Houttuynia cordata extract, Peony extract, Coix coix extract, Lavender extract, Oat extract, Ruscus aculeatus extract, Marshmallow extract, Poria cocos (Wolfiporia cocos) Extract, nettle extract, fennel extract, kiwi (Actinidia chinensis) extract, cucumber extract, grape extract, cactus extract, rehmannia root extract, quince extract, Cnidium officinale extract, mulberry extract, Thyme Extract, Horse Chestnut Extract, Peach Blossom (Prunus persica) Extract, Rosa damascena Extract, Apricot Tree Extract, Corn Extract, Ginger Extract, Lime Extract, Lime Extract, Strawberry Extract, Yellow Gentian Extract, Mallow Extract, Viola Extract, Burdock Extract, Lupine Extract, Carob Extract, Ivy Extract, Pine Extract, Rodgersia podophylla Extract, Burnet Extract, Miscanthus Pedicel Flower Extract, Gentiana Gentiana Extract, Hydrangea Extract, Fukutanpopodandelion Extract, Cydonia Seed Extract, Glycerin and 1,3-Butanediol.

本发明的皮肤外用制剂组合物可进一步的与其它具有诸如增白效果和细胞活化效果的成分适当混合。The skin external preparation composition of the present invention may further be appropriately mixed with other ingredients having effects such as whitening effect and cell activation effect.

上述的具有增白效果的成分的实例包括:维生素C及其衍生物和盐,胎盘提取物,甘草提取物,薏苡提取物,芦笋提取物,蔷薇果实提取物,悬钩子提取物,Sophora radix提取物,鸡血藤(Millettia reticulata)提取物,五加提取物,米糠提取物,麦芽提取物,堇菜提取物,野山楂提取物,(白百合)Lilium candidum提取物,芍药提取物,大豆提取物,茶叶提取物例如绿茶提取物,茶叶提取物和乌龙茶提取物,糖蜜提取物,白蔹提取物,山毛榉芽提取物,葡萄提取物,啤酒花提取物,玫瑰提取物,枣提取物,Siraitia grosvenori提取物,黄芩提取物,海藻提取物等等。Examples of the above-mentioned ingredients having a whitening effect include: vitamin C and its derivatives and salts, placenta extract, licorice extract, coix extract, asparagus extract, rose fruit extract, rabus extract, Sophora radix extract Extract, Millettia reticulata (Millettia reticulata) extract, Wujia extract, rice bran extract, malt extract, viola extract, wild hawthorn extract, (white lily) Lilium candidum extract, peony extract, soybean extract , tea leaf extracts such as green tea extract, tea leaf extract and oolong tea extract, molasses extract, white pomegranate extract, beech bud extract, grape extract, hop extract, rose extract, jujube extract, Siraitia grosvenori extract Extract, Scutellaria baicalensis extract, seaweed extract and so on.

进一步地,上述具有细胞活化效果的组分的实例包括:维生素A及其衍生物,柠檬酸,乳酸,酒石酸,苹果酸,乙醇酸,琥珀酸,丝氨酸,谷氨酸,羟脯氨酸,茶氨酸,吡咯烷酮羧酸酯,酵母提取物,乳酸杆菌提取物,双歧杆菌提取物,发酵代谢物提取物等等。在这些细胞活化剂中,尤其优选的是维生素A及其衍生物,柠檬酸,乳酸,苹果酸,丝氨酸和吡咯烷酮羧酸酯。Further, examples of the above-mentioned components having cell activation effects include: vitamin A and its derivatives, citric acid, lactic acid, tartaric acid, malic acid, glycolic acid, succinic acid, serine, glutamic acid, hydroxyproline, tea Amino acid, pyrrolidone carboxylate, yeast extract, lactobacillus extract, bifidobacterium extract, fermentation metabolite extract, etc. Among these cell activating agents, vitamin A and its derivatives, citric acid, lactic acid, malic acid, serine and pyrrolidone carboxylate are especially preferred.

此外,本发明的皮肤外用制剂组合物可广泛应用于诸如用于皮肤外部表层的化妆产品,用于头皮和毛发的组合物,用于皮肤清洁剂的组合物,药物,准药物。同样,其剂型可以是用于传统皮肤外用制剂的任一形式,只要其可适用于皮肤,例如溶液体系,诸如皮肤洗液的增溶体系,诸如乳液和乳膏的乳化体系,粉末分散体系,水-油两相体系,水-油-粉末三相体系,分散液体,软膏,凝胶,气雾剂等等。制备这些皮肤外用组合物时,其成分的类型和用量是可调节的,调节范围由本领域技术人员根据传统方法可合适地确定。In addition, the skin external preparation composition of the present invention can be widely applied to cosmetic products such as cosmetics for the outer surface of the skin, compositions for scalp and hair, compositions for skin cleansers, drugs, quasi-drugs. Also, its dosage form may be any form used in conventional skin external preparations as long as it is applicable to the skin, for example, solution system, solubilization system such as skin lotion, emulsification system such as lotion and cream, powder dispersion system, Water-oil two-phase system, water-oil-powder three-phase system, dispersion liquid, ointment, gel, aerosol, etc. When preparing these compositions for external use on skin, the types and amounts of the ingredients are adjustable, and the adjustment range can be suitably determined by those skilled in the art according to conventional methods.

另外,本发明的皮肤外用制剂组合物除了用作面部化妆产品诸如皮肤洗液,乳液,乳膏及面膜或粉底外,其使用形式也可任选地为粉底,擦面粉,口红,润唇剂,其它妆饰用化妆产品,用于特殊目的的化妆产品,用于身体的化妆产品,用于防晒或防晒癍的化妆产品,用于头皮和毛发的化妆产品,用于香料的化妆产品,面部清洁剂,用于头发的化妆产品(用于头皮和用于毛发),身体清洁剂,头发清洁剂(用于头皮和用于毛发),用于修面的化妆产品,用于洗浴的化妆产品等等。In addition, the skin external preparation composition of the present invention can also be optionally used as a foundation, face wipe, lipstick, lip balm, in addition to being used as a facial cosmetic product such as skin lotion, lotion, cream, and mask or foundation. , other make-up cosmetic products, cosmetic products for special purposes, cosmetic products for the body, cosmetic products for sun protection or sun protection, cosmetic products for the scalp and hair, cosmetic products for fragrance, facial cleansing cosmetic products for hair (for scalp and for hair), body cleansers, hair cleansers (for scalp and for hair), cosmetic products for shaving, cosmetic products for bathing, etc. wait.

同样,本发明的皮肤外用制剂的形式和用途并不受上述实例的限制。Also, the form and use of the external preparation for skin of the present invention are not limited to the above examples.

实施例Example

本发明将通过如下的非限制性检测实实施例和实施例进行更详细的说明。The invention will be illustrated in more detail by the following non-limiting test examples and examples.

下述检测目的在于检验由开菲乳颗粒得到的发酵乳制品所含成分对细胞的各种效果。首先,制备各个检测的样品。对发酵乳制品的固体物开菲乳进行离心,并去除沉淀。然后,用0.45μm滤膜进行过滤,并将其进样至NAP-25微型柱中,分子量为5000或以上的部分是流通组分,而分子量5000或以下的部分则被分成1,2,3和4组分。The purpose of the following tests is to examine the various effects on cells of the ingredients contained in fermented milk products obtained from kefir granules. First, prepare samples for each assay. The kefir solids of the fermented dairy product are centrifuged and the precipitate is removed. Then, filter it with a 0.45μm filter membrane and inject it into the NAP-25 microcolumn. The part with a molecular weight of 5000 or above is the flow-through component, while the part with a molecular weight of 5000 or below is divided into 1, 2, and 3 and 4 components.

实验实施例1:通过开菲乳(1)检测细胞活化作用Experimental example 1: detection of cell activation by kefir milk (1)

DNA常由于DNA复制错误或重组而导致错配突变,并且修复这种错配突变的错配修复基因(hMLH1,hPMS1,hPMS2,hMSH2,hMSH3和hMSH6)是已知的。当这些错配修复基因发生突变时,基因组会变得不稳定,并且有出现细胞恶性转化的危险。DNA often causes mismatch mutations due to DNA replication errors or recombination, and mismatch repair genes (hMLH1, hPMS1, hPMS2, hMSH2, hMSH3, and hMSH6) that repair such mismatch mutations are known. When these mismatch repair genes are mutated, the genome becomes unstable and the cells are at risk of malignant transformation.

将分子量5000或以上组分和组分3样品加入人恶性黑色素瘤细胞系HIV-I,并培养15小时。通过RT-PCR技术分析错配修复基因hMLH1,hPMS1和hPMS2的mRNAs表达量。结果证实了加入样品的细胞中表达量有增长。结果如图1到图4所示。The fraction with a molecular weight of 5000 or above and fraction 3 samples were added to the human malignant melanoma cell line HIV-I, and cultured for 15 hours. The expression levels of mRNAs of mismatch repair genes hMLH1, hPMS1 and hPMS2 were analyzed by RT-PCR. The results confirmed an increase in expression in the cells to which the samples were added. The results are shown in Figures 1 to 4.

实验实施例2:通过开菲乳(2)检测细胞活化作用Experimental example 2: detection of cell activation by kefir milk (2)

将实验实施例1中制备的组分3加入人恶性黑色素瘤细胞系HIV-I,培养5小时,并通过蛋白质印迹技术分析错配修复基因之一的hMLH1的蛋白表达量。结果,证实了加入开菲乳的细胞中表达量的增长。结果如图5和图6所示。Component 3 prepared in Experimental Example 1 was added to the human malignant melanoma cell line HIV-I, cultured for 5 hours, and the protein expression level of hMLH1, one of the mismatch repair genes, was analyzed by Western blotting. As a result, an increase in the expression level in cells to which kefir was added was confirmed. The results are shown in Figure 5 and Figure 6.

实验实施例3:通过开菲乳检测PCNA增长Experimental example 3: Detection of PCNA growth by kefir milk

已经知道PCNA(增殖细胞核抗原)是一种与细胞增殖或修复有很大关联的分子,并且在缺失PCNA的细胞中,其修复功能会严重缺乏。It is already known that PCNA (Proliferating Cell Nuclear Antigen) is a molecule closely related to cell proliferation or repair, and in cells lacking PCNA, its repair function will be severely lacking.

将组分3加入人恶性黑色素瘤细胞系HIV-I,并培养15小时。通过蛋白质印迹技术分析PCNA蛋白的表达量。结果证实了加入开菲乳的细胞中表达量有增长。结果如图7和图8所示。Fraction 3 was added to human malignant melanoma cell line HIV-I and cultured for 15 hours. The expression level of PCNA protein was analyzed by Western blotting. The results confirmed that the expression level in the cells added with kefir milk increased. The results are shown in Figure 7 and Figure 8.

实验实施例4:检测错配修复基因hMLH1表达的增强Experimental Example 4: Detection of enhancement of expression of mismatch repair gene hMLH1

(1)将组分3(3ml)进样至3ml的阴离子交换树脂DEAE柱中。将被吸附的物质用NaCl进行洗脱,脱盐,然后加入人恶性黑色素瘤细胞系HIV-I中,并培养15小时。通过RT-PCR技术证实了错配修复基因hMLHl的mRNAs表达量有一个增强效果。洗脱过程如下所示。(1) Inject component 3 (3ml) into a 3ml anion exchange resin DEAE column. The adsorbed substances were eluted with NaCl, desalted, and then added to the human malignant melanoma cell line HIV-I and incubated for 15 hours. It was confirmed by RT-PCR that the expression of mRNAs of the mismatch repair gene hMLH1 had an enhanced effect. The elution procedure is as follows.

流通组分Circulation components

         50mM磷酸钠缓冲液                   6ml50mM Sodium Phosphate Buffer 6ml

淋洗     50mM磷酸钠缓冲液                   6mlRinse 50mM Sodium Phosphate Buffer 6ml

组分1    50mM磷酸钠缓冲液                   6mlComponent 1 50mM Sodium Phosphate Buffer 6ml

组分2    50mM磷酸钠缓冲液0.15M NaCl         6mlComponent 2 50mM Sodium Phosphate Buffer 0.15M NaCl 6ml

组分3    50mM磷酸钠缓冲液0.15M NaCl         6mlComponent 3 50mM Sodium Phosphate Buffer 0.15M NaCl 6ml

组分4    50mM磷酸钠缓冲液1M NaCl            6mlComponent 4 50mM Sodium Phosphate Buffer 1M NaCl 6ml

组分5    50mM磷酸钠缓冲液1M NaCl            6mlComponent 5 50mM Sodium Phosphate Buffer 1M NaCl 6ml

将对照结果赋值为1,则每个样品的相对值如下,所作的图如图10所示。If the control result is assigned a value of 1, then the relative value of each sample is as follows, and the resulting figure is shown in Figure 10.

表1   对照 流通组分   淋洗   组分1   组分2   组分3   组分4   组分5   1.00     0.97     1.06     0.79     1.02     1.64     1.94     2.5 Table 1 control Circulation components rinse component 1 component 2 Component 3 Component 4 Component 5 1.00 0.97 1.06 0.79 1.02 1.64 1.94 2.5

(2)将组分3(3ml)进样至3ml的阳离子交换树脂DEAE柱中。将被吸附的物质用NaCl进行洗脱,脱盐,然后加入人恶性黑色素瘤细胞系HIV-I中,并培养15小时。通过RT-PCR技术证实了错配修复基因hMLH1的mRNA表达量有一个增强效果。洗脱过程如下所示。(2) Component 3 (3ml) was injected into a 3ml cation exchange resin DEAE column. The adsorbed substances were eluted with NaCl, desalted, and then added to the human malignant melanoma cell line HIV-I and incubated for 15 hours. The mRNA expression of the mismatch repair gene hMLH1 was confirmed to have an enhanced effect by RT-PCR technique. The elution procedure is as follows.

流通组分Circulation components

        50mM磷酸钠缓冲液                6ml50mM Sodium Phosphate Buffer 6ml

淋洗    50mM磷酸钠缓冲液                6mlRinse 50mM Sodium Phosphate Buffer 6ml

组分1    50mM磷酸钠缓冲液                  6mlComponent 1 50mM Sodium Phosphate Buffer 6ml

组分2    50mM磷酸钠缓冲液0.15M NaCl        6mlComponent 2 50mM Sodium Phosphate Buffer 0.15M NaCl 6ml

组分3    50mM磷酸钠缓冲液0.15M NaCl        6mlComponent 3 50mM Sodium Phosphate Buffer 0.15M NaCl 6ml

组分4    50mM磷酸钠缓冲液1M NaCl           6mlComponent 4 50mM Sodium Phosphate Buffer 1M NaCl 6ml

组分5    50mM磷酸钠缓冲液1M NaCl           6mlComponent 5 50mM Sodium Phosphate Buffer 1M NaCl 6ml

将对照结果赋值为1,每个样品的相对值如下,所作的图如图12所示。The control result is assigned a value of 1, and the relative values of each sample are as follows, and the resulting figure is shown in Figure 12.

表2   对照 流通组分   淋洗   组分1   组分2   组分3   组分4   组分5     1.00     1.46     1.61     1.29     1.38     1.98     1.93     1.83 Table 2 control Circulation components rinse component 1 component 2 Component 3 Component 4 Component 5 1.00 1.46 1.61 1.29 1.38 1.98 1.93 1.83

(3)将组分3改为进样至疏水柱中。将被吸附的物质用NaCl进行洗脱,脱盐,然后加入人恶性黑色素瘤细胞系HIV-I中,并培养15小时。通过RT-PCR技术证实了错配修复基因hMLH1的mRNA表达量有一个增强效果。洗脱过程如下所示。(3) Change component 3 into a hydrophobic column. The adsorbed substances were eluted with NaCl, desalted, and then added to the human malignant melanoma cell line HIV-I and incubated for 15 hours. The mRNA expression of the mismatch repair gene hMLH1 was confirmed to have an enhanced effect by RT-PCR technique. The elution procedure is as follows.

流通组分Circulation components

        100mM磷酸钠缓冲液      100mM Sodium Phosphate Buffer

        1.8M硫酸铵                    6ml1.8M ammonium sulfate 6ml

淋洗    100mM磷酸钠缓冲液Rinse with 100mM sodium phosphate buffer

        1.8M硫酸铵                    6ml1.8M ammonium sulfate 6ml

组分1   100mM磷酸钠缓冲液Component 1 100mM Sodium Phosphate Buffer

        1.8M硫酸铵                    6ml1.8M ammonium sulfate 6ml

组分2   100mM磷酸钠缓冲液Component 2 100mM Sodium Phosphate Buffer

        1.44M硫酸铵                   6ml1.44M ammonium sulfate 6ml

组分3   100mM磷酸钠缓冲液Component 3 100mM Sodium Phosphate Buffer

        1.44M硫酸铵                   6ml1.44M ammonium sulfate 6ml

组分4   100mM磷酸钠缓冲液             6mlComponent 4 100mM Sodium Phosphate Buffer 6ml

组分5    100mM磷酸钠缓冲液            6mlComponent 5 100mM Sodium Phosphate Buffer 6ml

将对照结果赋值为1,则每个样品的相对值如下,所作的图如图14所示。If the control result is assigned a value of 1, then the relative value of each sample is as follows, and the resulting figure is shown in Figure 14.

表3   对照 流通组分   淋洗   组分1   组分2   组分3   组分4   组分5     1.00     1.05     1.15     1.05     1.73     1.41     1.31     1.17 table 3 control Circulation components rinse component 1 component 2 Component 3 Component 4 Component 5 1.00 1.05 1.15 1.05 1.73 1.41 1.31 1.17

实验实施例5:检测开菲乳清的黑色素生成抑制效果Experimental example 5: Detection of melanin production inhibitory effect of kefir whey

对源自开菲乳发酵液的开菲乳清对人黑色素细胞系SK-MEL的黑色素生成的抗氧化剂作用效果进行了研究。考虑到开菲乳清将用于培养细胞体系,采用的样品为中和作用后在渗透压为0.300osmol/kg条件下制备得到。The antioxidant effect of kefir whey derived from kefir milk fermentation liquid on melanin production of human melanoma cell line SK-MEL was studied. Considering that the kefir whey will be used for culturing the cell system, the samples used are prepared under the condition of osmotic pressure of 0.300 osmol/kg after neutralization.

<实验方法><Experiment method>

将SK-MEL细胞以4×105细胞/毫升的细胞密度接种于5ml皿中。预培养后,将培养基更换为相对于培养基组分含0%(对照),0.1%和1%开菲乳清的培养基,并继续培养24小时。用胰蛋白酶处理回收细胞,在所有条件下均稀释至总细胞数为3×106个细胞,并回收至1.5ml管中。将该管离心(5000rpm,10min),将400μl的1M NaOH加入细胞沉淀中,100℃下煮沸10分钟。将溶胞产物充分混合,在每种条件下将三等份(100μl)置于96孔板中。然后通过板读数器检测405nm下的吸光度,并确定黑色素的量。Seed SK-MEL cells in a 5 ml dish at a cell density of 4 × 105 cells/ml. After the pre-cultivation, the medium was replaced with a medium containing 0% (control), 0.1% and 1% kefir whey relative to the medium components, and the culture was continued for 24 hours. Cells were recovered by trypsinization, diluted to a total cell number of 3 x 106 cells in all conditions, and recovered into 1.5 ml tubes. The tube was centrifuged (5000 rpm, 10 min), 400 μl of 1 M NaOH was added to the cell pellet, and boiled at 100° C. for 10 min. The lysates were mixed well and three aliquots (100 [mu]l) were plated in 96-well plates for each condition. Absorbance at 405 nm was then detected by a plate reader and the amount of melanin was determined.

<结果><result>

结果见于表4和图15。从结果可以看出当黑色素瘤在加入开菲乳清的培养基中培养时,其黑色素生成被明显抑制。The results are shown in Table 4 and Figure 15. It can be seen from the results that when the melanoma was cultured in the medium added with kefir whey, its melanin production was obviously inhibited.

表4     样品     平均吸光度     相对值(%)     对照     0.255     100     0.1%     0.219     85.9     1.0%     0.214     83.9 Table 4 sample Average absorbance relative value(%) control 0.255 100 0.1% 0.219 85.9 1.0% 0.214 83.9

实验实施例6:检测改善头皮和毛发的效果Experimental Example 6: Detection of the effect of improving scalp and hair

20名健康受试者(12名男性,8名女性)连续1个月使用含有发酵乳制品开菲乳的护发产品。通过每天洗发后施用该产品于头皮和毛发上,主要在发痒部位,观察头发光泽,头皮屑,毛发脱落和头皮瘙痒进行检测。Twenty healthy subjects (12 males, 8 females) used hair care products containing kefir, a fermented dairy product, for one month. Tested by applying the product on the scalp and hair after shampooing daily, mainly in itchy areas, observing hair shine, dandruff, hair loss and scalp itching.

结果如下。The result is as follows.

头发光泽:Hair Shine:

改善:12例,无改变:6例,恶化:0例,未知:2例Improvement: 12 cases, no change: 6 cases, deterioration: 0 cases, unknown: 2 cases

头皮屑:Dandruff:

显著减少:8例,无改变:10例,恶化:0例未知:2例Significant reduction: 8 cases, no change: 10 cases, deterioration: 0 cases Unknown: 2 cases

毛发脱落:Hair loss:

减少:5例,无改变:12例,恶化:1例,未知:2例Reduction: 5 cases, no change: 12 cases, deterioration: 1 case, unknown: 2 cases

头皮瘙痒:Itchy scalp:

减少:9例,无改变:8例,恶化:1例,未知:2例Reduction: 9 cases, no change: 8 cases, deterioration: 1 case, unknown: 2 cases

结果表明含有开菲乳的护发产品作为用于头皮和毛发的组合物是有效果的,可以改善毛发光泽,减少头皮屑,减少毛发脱落,并可预防头皮瘙痒。The results show that the hair care product containing kefir milk is effective as a composition for scalp and hair, can improve hair luster, reduce dandruff, reduce hair loss, and prevent scalp itching.

实验实施例7:采用了含发酵乳制品开菲乳的一种凝胶(商标名:kefran),结果如下。Experimental Example 7: A gel containing fermented dairy product kefir (trade name: kefran) was used, and the results are as follows.

(1)26岁女性:我所用过的几乎所有皮肤洗液等中,每次我将它们倒入手掌时,它们一接触我手指上由于特异反应性而形成的伤口时,都痛的直跳,直至现在也这样。因此当我姐姐推荐kefran时,我很担心它会以同样的方式伤害我,然而事实上根本没有。当然,我可以将它施用于脸上,没有任何痛感,因此从今以后我可以没有任何担心的使用它了。(1) 26 year old female: Of almost all the skin lotions etc. I've ever used, every time I pour them into my palms, they throb so painfully when they touch the wounds on my fingers due to atopy , until now. So when my sister recommended kefran, I was worried it would hurt me in the same way, when in fact it didn't. Of course, I can apply it on my face without any pain, so from now on I can use it without any worries.

(2)34岁女性:我的第二个孩子出生后,我产生特异反应性,并且我的皮肤变得非常敏感。部分由于我的年龄的原因,过去我对使用时具有温和触感的护肤产品不满意,一直寻求好的产品,自从买了kefran后我现在一直用它。真的非常好。(2) 34-year-old female: After my second child was born, I developed atopy and my skin became very sensitive. Partly due to my age, I used to be dissatisfied with skincare products that have a gentle touch on application, have been looking for a good product, and since buying kefran I have been using it now. Really very good.

(3)23岁女性:以前我一直为寻找一种适合我的特异反应性皮肤的基础护肤产品而苦恼,但是自从我用了kefran后,我的皮肤得到了显著改善。(3) 23-year-old female: I used to struggle to find a basic skin care product suitable for my atopic skin, but since I used kefran, my skin has improved significantly.

(4)45岁女性:我对日光敏感。我的脸等等可以通过化妆、戴帽子等避免日光的伤害。然而,如果我的手背和胳膊时不时暴露于太阳底下,到晚上皮肤就会变得象goosebump似的,并且剧烈的瘙痒令我痛苦不堪。当我注意到这个问题时,如果及早使用kefran,我的皮肤会很快得到恢复,并且剧烈的瘙痒也会得到缓解。(4) 45-year-old female: I am sensitive to sunlight. My face, etc. can be protected from sun damage with makeup, hats, etc. However, if the backs of my hands and arms are exposed to the sun from time to time, at night the skin turns into a goosebump and the intense itching is excruciating. When I noticed this problem, if I used kefran early, my skin recovered quickly and the severe itching was relieved.

实施例1:乳膏Example 1: cream

<配方(重量%)><Recipe (weight%)>

(1)聚氧乙烯(40E.O.)一硬脂酸          2.00(1) Polyoxyethylene (40E.O.)-stearic acid 2.00

(2)甘油一硬脂酸酯(自乳化型)          5.00(2) Glyceryl monostearate (self-emulsifying type) 5.00

(3)硬脂酸                            5.00(3) Stearic acid 5.00

(4)二十二烷醇                        0.50(4) Docosanol 0.50

(5)角鲨烯                            15.00(5) Squalene 15.00

(6)十六烷基异辛酸酯                  5.00(6) Cetyl isooctanoate 5.00

(7)抗菌剂                            适量(7) Appropriate amount of antibacterial agent

(8)1,3-丁二醇                       5.00(8) 1,3-Butanediol 5.00

(9)开菲乳滤液                        1.00(9) Kefi milk filtrate 1.00

(10)纳豆提取物                  1.00(10)Natto Extract 1.00

(11)大豆提取物                  0.20(11) Soybean extract 0.20

(12)虎耳草提取物                0.10(12) Saxifrage Extract 0.10

(13)黄瓜提取物                  0.10(13) Cucumber Extract 0.10

(14)甘草提取物                  0.10(14) Licorice Extract 0.10

(15)甘草酸二钾                  0.05(15)Dipotassium glycyrrhizinate 0.05

(16)桑提取物                    0.05(16) Mulberry extract 0.05

(17)黄芩提取物                  0.05(17)Scutellaria baicalensis extract 0.05

(18)角蛋白水解液                1.00(18) Keratin Hydrolyzate 1.00

(19)香料                        适量(19) Appropriate amount of spices

(20)纯化水                      余量(20) Balance of purified water

<制备过程><Preparation process>

上述成分(1)至(7)在70℃加热条件下溶解。然后,将(8)和一部分(20)加热至70℃并加入前面的溶解成分中,然后,待冷却时将成分(9)至(18),(19)和剩余部分的(20)加入,从而得到乳膏。The above components (1) to (7) were dissolved under heating at 70°C. Then, (8) and a portion of (20) are heated to 70°C and added to the previously dissolved ingredients, then, while cooling, ingredients (9) to (18), (19) and the remaining portion of (20) are added, Thereby a cream is obtained.

实施例2:洗液Example 2: Lotion

<配方(重量%)><Recipe (weight%)>

(1)甘油                                   5.00(1) Glycerin 5.00

(2)1,3-丁二醇                            6.50(2) 1,3-Butanediol 6.50

(3)聚氧乙烯(20mol)脱水山梨醇一月桂酸酯    1.20(3) Polyoxyethylene (20mol) sorbitan monolaurate 1.20

(4)乙醇                                   8.00(4) Ethanol 8.00

(5)开菲乳滤液                             1.00(5) Kefi milk filtrate 1.00

(6)纳豆提取物                             1.00(6) Natto Extract 1.00

(7)抗菌剂,抗氧化剂                       适量(7) Antibacterial agents, antioxidants Appropriate amount

(8)香料                                   适量(8) Appropriate amount of spices

(9)纯化水                                 余量(9) Purified water Balance

<制备过程><Preparation process>

首先,将上述成分(3),(4),(7)和(8)混合并溶解,然后将(1),(2),(5),(6)和(9)混合并溶解。将这些混合并溶解的成分进一步均匀混合,这样即得到洗液。First, the above ingredients (3), (4), (7) and (8) were mixed and dissolved, and then (1), (2), (5), (6) and (9) were mixed and dissolved. These mixed and dissolved ingredients are further uniformly mixed, thus obtaining a lotion.

实施例(3):乳液Embodiment (3): emulsion

<配方(重量%)><Recipe (weight%)>

(1)硬脂酸                                 1.50(1) Stearic acid 1.50

(2)十六烷醇                               0.50(2) Cetyl alcohol 0.50

(3)蜂蜡                                   2.00(3) Beeswax 2.00

(4)聚氧乙烯(20mol)一油酸酯                1.00(4) Polyoxyethylene (20mol) monooleate 1.00

(5)甘油一硬脂酸酯                         1.00(5) Glyceryl monostearate 1.00

(6)乙醇                                   10.00(6) Ethanol 10.00

(7)熊果苷                                 20.00(7) Arbutin 20.00

(8)亚硫酸氢钠                             0.03(8) Sodium bisulfite 0.03

(9)丙二醇                                 5.00(9) Propylene Glycol 5.00

(10)开菲乳滤液                            1.00(10) Kefi milk filtrate 1.00

(11)纳豆提取物                            1.00(11) Natto Extract 1.00

(12)大豆提取物                            0.20(12) Soybean extract 0.20

(13)虎耳草提取物                          0.10(13) Saxifrage Extract 0.10

(14)黄瓜提取物                            0.10(14) Cucumber Extract 0.10

(15)甘草提取物                            0.10(15) Licorice Extract 0.10

(16)甘草酸二钾                            0.05(16)Dipotassium glycyrrhizinate 0.05

(17)桑提取物                              0.05(17) Mulberry Extract 0.05

(18)黄芩提取物                            0.05(18)Scutellaria baicalensis extract 0.05

(19)香料                                  适量(19) Spices Appropriate amount

(20)抗菌剂,抗氧化剂                      适量(20) Antibacterial agents, antioxidants Appropriate amount

(21)纯化水                                余量(21) Purified water Balance

<制备过程><Preparation process>

将上述成分(7)、(9)和(10)至(18)加入(21)中,加热条件下溶解,并保持70℃以形成水相。将成分(19)加入(6)中并溶解以形成醇相。将成分(1)至(5),(8)和(20)混合,加热条件下溶解,并保持70℃以形成油相。将油相加入水相进行初乳化,然后通过均匀搅拌机进行均匀乳化作用。于搅拌时将醇相加入,然后搅拌时将所得到的混合物冷却至30℃,这样即得到乳液。The above-mentioned ingredients (7), (9) and (10) to (18) were added to (21), dissolved under heating, and kept at 70° C. to form an aqueous phase. Ingredient (19) was added to (6) and dissolved to form the alcoholic phase. Ingredients (1) to (5), (8) and (20) were mixed, dissolved under heating, and kept at 70° C. to form an oil phase. The oil phase is added to the water phase for initial emulsification, and then uniform emulsification is carried out by a homogeneous mixer. The alcoholic phase was added with stirring, and the resulting mixture was cooled to 30°C while stirring, thus obtaining an emulsion.

实施例4:凝胶剂Embodiment 4: Gel

<配方(重量%)><Recipe (weight%)>

(1)1,3-丁二醇                          5.00(1) 1,3-Butanediol 5.00

(2)海藻糖溶液                           3.00(2) Trehalose solution 3.00

(3)开菲乳滤液                           1.00(3) Kefi milk filtrate 1.00

(4)纳豆提取物                           1.00(4) Natto Extract 1.00

(5)海藻提取物                           1.00(5) Seaweed Extract 1.00

(6)尿素                                 0.80(6) Urea 0.80

(7)聚羧乙烯                             0.80(7) Carboxyvinyl 0.80

(8)甘油                                 0.50(8) Glycerin 0.50

(9)L-抗坏血酸-磷酸镁                    0.50(9)L-Ascorbic acid-magnesium phosphate 0.50

(10)氢氧化钾                            0.50(10) Potassium hydroxide 0.50

(11)苯氧基乙醇                          0.30(11) Phenoxyethanol 0.30

(12)羧甲基纤维素钠                      0.20(12) Sodium carboxymethylcellulose 0.20

(13)大豆提取物                          0.20(13) Soybean extract 0.20

(14)虎耳草提取物                        0.10(14) Saxifrage Extract 0.10

(15)黄瓜提取物                          0.10(15) Cucumber Extract 0.10

(16)甘草提取物                          0.10(16) Licorice Extract 0.10

(17)甘草酸二钾                          0.05(17)Dipotassium glycyrrhizinate 0.05

(18)桑提取物                            0.05(18) Mulberry extract 0.05

(19)黄芩提取物                          0.05(19)Scutellaria baicalensis extract 0.05

(20)纯化水                              84.75(20) Purified water 84.75

<制备过程><Preparation process>

将上述成分(3)至(8)和(13)至(19)均匀溶解于(20)中以形成水相。另一面,将(1)、(2)、(9)和(11)溶解并加入水相中。然后,将混合物用(10)和(12)进行中和和增稠,这样即得到凝胶。The above-mentioned ingredients (3) to (8) and (13) to (19) are uniformly dissolved in (20) to form an aqueous phase. On the other hand, (1), (2), (9) and (11) were dissolved and added to the water phase. Then, the mixture is neutralized and thickened with (10) and (12), so that a gel is obtained.

实施例5:剥离型面膜Embodiment 5: peel-off mask

<配方(重量%)><Recipe (weight%)>

(1)95%乙醇                                10.00(1) 95% ethanol 10.00

(2)聚氧乙烯(15mol)油醇醚                   2.00(2) Polyoxyethylene (15mol) oleyl ether 2.00

(3)抗菌剂,抗氧化剂                        适量(3) Antibacterial agents, antioxidants Appropriate amount

(4)香料                                    适量(4) Appropriate amount of spices

(5)乳清                                    1.00(5) Whey 1.00

(6)海藻提取物                              1.00(6) Seaweed Extract 1.00

(7)甘草酸二钾                              0.05(7) Dipotassium glycyrrhizinate 0.05

(8)聚乙烯醇                                12.00(8) Polyvinyl alcohol 12.00

(9)甘油                                    3.00(9) Glycerin 3.00

(10)聚乙二醇                               1.00(10) Polyethylene glycol 1.00

(11)纯化水                                 余量(11) Purified water Balance

<制备过程><Preparation process>

从上述成分(5)至(11)在80℃下制备水相,并冷却至50℃。然后,在室温下将成分(1)至(4)制备生成一个醇相,将该醇相加入水相中,并均匀混合。然后将混合物冷却,这样即得到面膜。An aqueous phase was prepared at 80°C from the above ingredients (5) to (11), and cooled to 50°C. Then, ingredients (1) to (4) were prepared at room temperature to form an alcohol phase, which was added to the water phase and mixed uniformly. The mixture is then cooled, so that a mask is obtained.

实施例6:液体粉底Example 6: Liquid Foundation

<配方(重量%)><Recipe (weight%)>

(1)羊毛脂                            7.00(1) Lanolin 7.00

(2)液体石蜡                          5.00(2) Liquid paraffin 5.00

(3)硬脂酸                            2.00(3) Stearic acid 2.00

(4)十六烷醇                                 1.00(4) Cetyl alcohol 1.00

(5)2-乙基己基对-甲氧基肉桂酸酯              3.00(5) 2-Ethylhexyl p-methoxycinnamate 3.00

(6)甘油                                     5.00(6) Glycerin 5.00

(7)三乙醇胺                                 1.00(7) Triethanolamine 1.00

(8)羧甲基纤维素                             0.70(8)Carboxymethylcellulose 0.70

(9)纯化水                                   余量(9) Purified water Balance

(10)二氧化钛                                8.00(10) Titanium dioxide 8.00

(11)微粒化二氧化钛                          2.00(11) Micronized titanium dioxide 2.00

(12)氧化锌                                  5.00(12)Zinc Oxide 5.00

(13)云母                                    15.00(13)Mica 15.00

(14)滑石                                    6.00(14) Talc 6.00

(15)色素                                    6.00(15)Pigment 6.00

(16)开菲乳滤液                              0.50(16) Kefi milk filtrate 0.50

(17)桑提取物                                0.05(17) Mulberry Extract 0.05

(18)黄芩提取物                              0.05(18)Scutellaria baicalensis extract 0.05

(19)香料                                    适量(19) Spices Appropriate amount

<制备过程><Preparation process>

首先,将上述成分(1)至(5)混合并溶解。然后,加入成分(10)至(15),均匀混合,并保持温度70℃。随后,将(6)至(9)均匀溶解,保持在70℃,并加入前面的溶解混合物中,并进行均匀乳化。First, the above-mentioned ingredients (1) to (5) are mixed and dissolved. Then, ingredients (10) to (15) were added, mixed uniformly, and the temperature was maintained at 70°C. Subsequently, (6) to (9) were uniformly dissolved, kept at 70° C., and added to the previous dissolved mixture, and uniformly emulsified.

待所得混合物冷却后,加入成分(16)至(19),这样即得到液体粉底。After the resulting mixture was cooled, ingredients (16) to (19) were added, whereby a liquid foundation was obtained.

对本发明的皮肤外用制剂的感觉评测Sensory evaluation of the skin external preparation of the present invention

邀请了20名女性使用含有用开菲乳颗粒得到的发酵乳制品的皮肤外用制剂,每天早晚洗脸后将制剂施用于整个面部,连用3个月,其效力由一名医生进行评测。20 women were invited to use the skin external preparation containing fermented milk products obtained from kefir milk granules. The preparation was applied to the entire face after washing the face every morning and evening for 3 months, and its efficacy was evaluated by a doctor.

I.干性皮肤I. Dry skin

1.非常有效                            11例1. Very effective 11 cases

2.有效                                6例2. Effective in 6 cases

3.无变化                              5例3. No change 5 cases

4.恶化                                0例4. Deterioration 0 cases

II.对面部黄褐斑的效力II. Efficacy on Facial Melasma

1.非常有效                            6例1. Very effective in 6 cases

2.有效                                9例2. Effective in 9 cases

3.无变化                              4例3. No change 4 cases

4.恶化                                1例4. 1 case of deterioration

III.硬性肤质III. Hard skin

1.非常有效                            3例1. Very effective 3 cases

2.有效                                8例2. Effective 8 cases

3.无变化                              8例3. No change 8 cases

4.恶化                                1例4. 1 case of deterioration

从上述评测可以明显看出,根据本发明的皮肤外用制剂对于干性皮肤,斑点和硬性肤质是安全和有效的,并且可以提高皮肤细胞活性。It is evident from the above evaluation that the skin external preparation according to the present invention is safe and effective for dry skin, blemishes and hard skin, and can increase skin cell activity.

工业实用性Industrial Applicability

从开菲乳颗粒得到的发酵乳制品具有广泛用途,包括保湿效果,紫外线防护效果,黑色素生成抑制效果和自由基清除效果。同时它还具有热稳定性,并可进行过滤除菌,这就使其有可能用作稳定的皮肤外用制剂,特别是化妆品原料。然而,它具有独特的酵母发酵和乳酸发酵气味,以及4.20-4.40的pH。因而可以认为,通过与其他化妆品原料适当混合,证实当使用时具有舒适的触感,并且具有由开菲乳颗粒得到的发酵乳制品所表现出来的最初效果和效力。Fermented milk products obtained from kefir granules have a wide range of uses, including moisturizing effects, UV protection effects, melanin production inhibitory effects, and free radical scavenging effects. At the same time, it is heat stable and can be sterilized by filtration, which makes it possible to be used as a stable external preparation for skin, especially as a raw material for cosmetics. However, it has a distinctive yeasty and lactic acid fermented smell, and a pH of 4.20-4.40. It can thus be considered that, by being properly mixed with other cosmetic raw materials, it is confirmed that it has a pleasant touch when used, and has the initial effect and potency exhibited by fermented milk products obtained from kefir granules.

Claims (20)

1. a preparation for external application to skin compositions contains the fermented dairy product and the medicinal or used for cosmetic carrier that obtain from the kefir granule.
2. according to the preparation for external application to skin compositions of claim 1, further contain one or more following components: free radical scavenging component, antioxidant ingredients, antiinflammatory component, ultraviolet protection component and the component of preserving moisture.
3. according to the preparation for external application to skin compositions of claim 1 or 2, wherein the fermented dairy product that obtains from the kefir granule is that kefir and/or kefir are clear.
4. according to the preparation for external application to skin compositions of claim 3, wherein the content that kefir and/or kefir are clear is the 0.01-3.00wt% of total composition.
5. according to the preparation for external application to skin compositions of claim 1 to 4, wherein the preparation for external application to skin compositions is a liquid, emulsion, gel, emulsifiable paste, arbitrary form of paste or thin slice.
6. according to each preparation for external application to skin compositions of claim 1 to 5, wherein the preparation for external application to skin compositions is a kind of cosmetic composition.
7. according to the preparation for external application to skin compositions of claim 6, cosmetic composition wherein is a kind of cosmetic composition that is used for health.
8. according to the preparation for external application to skin compositions of claim 7, the cosmetic composition that wherein is used for health is a kind of composition of skin cleanser.
9. according to each preparation for external application to skin compositions of claim 1 to 5, preparation for external application to skin compositions wherein is a kind of compositions that is used for scalp and hair.
10. activation Skin Cell, the prevention skin aging suppresses melanin biosynthesis in the skin, and/or the method for skin whitening, and described method is the fermented dairy product that obtains from the kefir granule to the dermal administration effective dose.
11., be a kind of method that skin is made up or cleaned that is used for according to the method for claim 10.
12., be a kind of method that is used for scalp and/or hair makeup or cleaning according to the method for claim 10.
13., be a kind of method for the treatment of dermatosis patient skin according to the method for claim 10.
14. according to the method for claim 10, wherein the fermented dairy product that obtains from the kefir granule is that kefir and/or kefir are clear.
15. the application of the fermented dairy product that obtains from the kefir granule during producing the preparation for external application to skin compositions.
16. according to the application of claim 15, wherein the fermented dairy product that obtains from the kefir granule is that kefir and/or kefir are clear.
17. a cell activator contains the fermented dairy product that obtains from the kefir granule.
18. a resisting age of skin agent contains the fermented dairy product that obtains from the kefir granule.
19. a skin whitener contains the fermented dairy product that obtains from the kefir granule.
20. a Melanin inhibitor contains the fermented dairy product that obtains from the kefir granule.
CNB038048922A 2002-02-28 2003-02-28 Composition for external application to skin Expired - Fee Related CN100551348C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002054787 2002-02-28
JP54787/2002 2002-02-28

Publications (2)

Publication Number Publication Date
CN1638784A true CN1638784A (en) 2005-07-13
CN100551348C CN100551348C (en) 2009-10-21

Family

ID=27764413

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038048922A Expired - Fee Related CN100551348C (en) 2002-02-28 2003-02-28 Composition for external application to skin

Country Status (5)

Country Link
JP (1) JP4252460B2 (en)
KR (1) KR100992101B1 (en)
CN (1) CN100551348C (en)
AU (1) AU2003211453A1 (en)
WO (1) WO2003072119A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101588809A (en) * 2006-12-26 2009-11-25 明治乳业株式会社 Fermented milk for skin improvement and/or treatment and method for producing same
CN101999997A (en) * 2010-11-27 2011-04-06 天津市顶硕科贸有限公司 Desensitizing facial mask containing sodium azulene sulfonate
CN101507698B (en) * 2009-03-25 2011-04-20 天津郁美净集团有限公司 Composite with whitening function and skin care product thereof and preparation method thereof
CN103349592A (en) * 2013-07-25 2013-10-16 钟春燕 Paper diaper with good water-absorbing quality
CN108553374A (en) * 2018-06-26 2018-09-21 湖南御家化妆品制造有限公司 Composition and application thereof in preparation of cosmetics with anti-inflammatory function
CN109303743A (en) * 2018-11-21 2019-02-05 柳州两面针股份有限公司 Application of traditional Chinese medicine composition in the preparation of skin care products
CN112545949A (en) * 2021-01-15 2021-03-26 东晟源研究院(广州)有限公司 Composition with effects of resisting oxidation and homogenizing skin color and preparation method thereof
CN113181086A (en) * 2021-04-06 2021-07-30 厦门医学院 Application of saussurea involucrata bacteria fermentation product in inhibiting tyrosinase activity and melanin generation

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005348698A (en) * 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk Microorganism culture obtained by culturing microorganisms isolated from kefir grains and this microorganism or a group of microorganisms containing the same, and products using them
JP2006124290A (en) * 2004-10-27 2006-05-18 Yonezawa Biru System Service:Kk Microbial cultures obtained from a medium mainly composed of mugwort extract and products using them
JP4085140B2 (en) * 2005-03-28 2008-05-14 株式会社 米沢ビルシステムサービス Microbial culture obtained in medium containing green tea and black tea
JP4085141B2 (en) * 2005-03-28 2008-05-14 株式会社 米沢ビルシステムサービス Microbial culture obtained on medium containing green tea, black tea and mugwort extract
GB0513193D0 (en) * 2005-06-29 2005-08-03 Quest Int Serv Bv Improvements in skin and hair care
KR100829596B1 (en) * 2006-02-22 2008-05-14 한국화학연구원 Cucumber Herbal Extract with Antioxidant Activity
KR100782517B1 (en) 2006-03-22 2007-12-06 (주)아르떼르화장품 Cosmetic composition for antioxidant or skin irritation relief containing plant extract
CN102465182A (en) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 Detection kit for detecting skin active substance and method for detecting skin active substance
FR2968990B1 (en) * 2010-12-17 2013-02-22 Oreal "USE OF STABLE MICROBIAL POPULATION AS AN AGENT FOR STIMULATING THE EPIDERMIC REGENERATION OF SKIN FOLLOWING COSMETIC TREATMENT OF A CHEMICAL AND / OR MECHANICAL AND / OR PHYSICAL NATURE"
FR2968991B1 (en) * 2010-12-17 2013-01-11 Oreal "USE OF STABLE MICROBIAL POPULATION TO PREVENT AND / OR TREAT THE DISORDERS OF FRAGILIZED OR DAMAGED LIP"
KR102249700B1 (en) * 2014-04-24 2021-05-10 (주)아모레퍼시픽 Comsmetic composition comprising mint vinegar
KR102098914B1 (en) * 2016-11-29 2020-04-09 청미바이오(주) Composition of anti-inflammatory or anti-oxidation containing natto and kefir fermented component
KR102417303B1 (en) * 2017-11-24 2022-07-06 (주)아모레퍼시픽 Composition for preventing or improving atopic dermatitis
CN108904420A (en) * 2018-06-28 2018-11-30 爱思开百朗德生物科技(海门)有限公司 Raw material of skin care articles composition with acne-removing and preparation method thereof, application

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622797B1 (en) * 1987-11-05 1991-02-01 Oreal COSMETIC COMPOSITION BASED ON YOGURT OR KEFIR
JPH05301812A (en) * 1992-04-23 1993-11-16 Sansho Seiyaku Co Ltd Skin external preparation
FR2704753B1 (en) * 1993-05-06 1995-06-30 Oreal USE OF DERIVATIVES OF 4-THIO RESORCIN OR 4-THIO 1-3-DIHYDROXYBENZENE, IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS WITH DEPIGMENTING ACTION.
JPH0710734A (en) * 1993-06-21 1995-01-13 Dowa Mining Co Ltd Cosmetic
DE4411108A1 (en) * 1994-03-30 1995-10-05 Basf Ag Use of co-fermented milk prods. to prepare medicaments
WO1996003052A1 (en) * 1994-07-22 1996-02-08 The Good Life Company And Friends Pty Ltd. Starter culture receptacle and methods using the same
US5979300A (en) * 1994-07-22 1999-11-09 Kefir Culture Natural Limited Starter culture receptacle and methods using the same
JPH08333220A (en) * 1995-06-12 1996-12-17 Pola Chem Ind Inc Selection of cosmetic
JP2000119156A (en) * 1998-10-14 2000-04-25 Kose Corp Skin lotion
JP2000128762A (en) * 1998-10-28 2000-05-09 Kose Corp Melanogenesis inhibitor and skin preparation for external use for beautifying containing the same
JP2000229828A (en) * 1999-02-05 2000-08-22 Kose Corp Skin bleaching lotion
JP2001181198A (en) * 1999-10-14 2001-07-03 Nisshin Oil Mills Ltd:The Skin-beautifying agent, skin aging-preventing agent, bleaching agent and skin care preparation
JP4015792B2 (en) * 1999-12-10 2007-11-28 株式会社コーセー Whitening agent and external preparation for skin containing it as an active ingredient
JP2001181173A (en) * 1999-12-27 2001-07-03 Kose Corp Bleaching preparation for external use
JP2001261570A (en) * 2000-03-22 2001-09-26 Nisshin Oil Mills Ltd:The Skin care preparation

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101588809A (en) * 2006-12-26 2009-11-25 明治乳业株式会社 Fermented milk for skin improvement and/or treatment and method for producing same
CN101588809B (en) * 2006-12-26 2013-04-24 株式会社明治 Fermented milk for skin improvement and/or treatment and method for producing same
CN101507698B (en) * 2009-03-25 2011-04-20 天津郁美净集团有限公司 Composite with whitening function and skin care product thereof and preparation method thereof
CN101999997A (en) * 2010-11-27 2011-04-06 天津市顶硕科贸有限公司 Desensitizing facial mask containing sodium azulene sulfonate
CN101999997B (en) * 2010-11-27 2012-08-22 天津市顶硕科贸有限公司 Desensitizing facial mask containing sodium azulene sulfonate
CN103349592A (en) * 2013-07-25 2013-10-16 钟春燕 Paper diaper with good water-absorbing quality
CN108553374A (en) * 2018-06-26 2018-09-21 湖南御家化妆品制造有限公司 Composition and application thereof in preparation of cosmetics with anti-inflammatory function
CN108553374B (en) * 2018-06-26 2021-06-04 湖南御家化妆品制造有限公司 Composition and application thereof in preparation of cosmetics with anti-inflammatory function
CN109303743A (en) * 2018-11-21 2019-02-05 柳州两面针股份有限公司 Application of traditional Chinese medicine composition in the preparation of skin care products
CN109303743B (en) * 2018-11-21 2021-05-25 柳州两面针股份有限公司 Application of traditional Chinese medicine composition in preparation of skin care product
CN112545949A (en) * 2021-01-15 2021-03-26 东晟源研究院(广州)有限公司 Composition with effects of resisting oxidation and homogenizing skin color and preparation method thereof
CN113181086A (en) * 2021-04-06 2021-07-30 厦门医学院 Application of saussurea involucrata bacteria fermentation product in inhibiting tyrosinase activity and melanin generation
CN113181086B (en) * 2021-04-06 2023-11-17 厦门医学院 Application of snow lotus fermentation product in inhibiting tyrosinase activity and melanin production

Also Published As

Publication number Publication date
JP4252460B2 (en) 2009-04-08
KR20040111367A (en) 2004-12-31
CN100551348C (en) 2009-10-21
KR100992101B1 (en) 2010-11-04
AU2003211453A1 (en) 2003-09-09
WO2003072119A1 (en) 2003-09-04
JPWO2003072119A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
CN1638784A (en) skin topical composition
CN1196469C (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
CN1297266C (en) Stabilized ascorbic acid derivatives
CN1933805A (en) Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides
CN101048133A (en) Skin preparation for external use
CN1197542C (en) Cosmetics
CN1187060C (en) Extracts of shark cartilage
CN1753968A (en) Antioxidant composition and composition for external use
CN1094342C (en) Cosmetic preparation with peptide addition
CN1152667C (en) Antisebum and antioxidant composition
CN1921823A (en) Anti-aging agent and collagen production promoter
CN1162144C (en) Ultraviolet absorbing composition
CN1484521A (en) Inhibitor or repairing agent for skin damage caused by dryness and method for evaluating the same
CN1409637A (en) Skin beautifying agent, anti-aging agent for skin, whitening agent for skin and external preparation
CN1465338A (en) Skin activating composition for external used anti-aging preparation
CN1870972A (en) Cosmetic composition comprising camel milk or components thereof
CN101043869A (en) Hair care preparations
CN1382033A (en) Comestios
CN1863543A (en) Dietetic composition
CN1778287A (en) Increased moisturization efficacy using hydroxyalkylurea
CN1960698A (en) Topical slimming preparations and cosmetics containing carnitine derivatives
CN1826127A (en) Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue
CN1545402A (en) Substance capable of enhancing production of laminin 5 in epidermal cells and use thereof
CN1249677A (en) Composition for external use
CN1706378A (en) Inflammation inhibitor containing zinc pyrrolidonecarboxylate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091021

Termination date: 20190228

CF01 Termination of patent right due to non-payment of annual fee